TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
36,237,639
|
31,741,662
|
25,728,161 |
| Financial expenses |
20,239
|
37,403
|
217,450 |
| Earnings before taxes |
4,884,881
|
5,693,016
|
4,839,136 |
| EBITDA |
6,446,532
|
7,246,421
|
6,497,511 |
| Total assets |
49,185,949
|
47,108,542
|
39,708,996 |
| Current assets |
36,376,949
|
33,692,804
|
27,827,217 |
| Current liabilities |
4,611,853
|
4,440,123
|
4,006,545 |
| Equity capital |
42,505,059
|
40,274,418
|
33,739,488 |
| - share capital |
1,332
|
1,335
|
1,230 |
| Employees (average) |
10,587
|
9,734
|
8,336 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.4%
|
85.5%
|
85.0% |
| Turnover per employee |
3,423
|
3,261
|
3,086 |
| Profit as a percentage of turnover |
13.5%
|
17.9%
|
18.8% |
| Return on assets (ROA) |
10.0%
|
12.2%
|
12.7% |
| Current ratio |
788.8%
|
758.8%
|
694.5% |
| Return on equity (ROE) |
11.5%
|
14.1%
|
14.3% |
| Change turnover |
4,495,977
|
6,013,501
|
1,713,101 |
| Change turnover % |
14%
|
23%
|
7% |
| Chg. No. of employees |
853
|
1,398
|
195 |
| Chg. No. of employees % |
9%
|
17%
|
2% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.